CAMP4 THERAPEUTICS CORPORATION CAMP
3.84 USD +0.12 (+3.32%)
Nov 6, 2026, 12:45 PM EST
3.66 Day range 3.86
2.90 52-week range 7.75
- YTD
- -37.30%
- 1 year
- -13.63%
Ownership
Held by insiders 36.59%
Held by institutions 42.04%
Float held by institutions 66.30%
Institutions 5
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Select Portfolios - Biotechnology | 1.13% | 227,300 | 1.72M | Oct 30, 2024 |
| Fidelity Growth Company Fund | 0.85% | 171,200 | 1.30M | Oct 30, 2024 |
| Fidelity Growth Company K6 Fund | 0.26% | 52,404 | 397.22K | Oct 30, 2024 |
| Fidelity Series Growth Company Fund | 0.22% | 43,500 | 329.73K | Oct 30, 2024 |
Top mutual fund holders
No holders on record
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 5AM PARTNERS VI, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 14, 2024 | 0 |
| AH EQUITY PARTNERS BIO I, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 14, 2024 | 0 |
| ENAVATE SCIENCES GP, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 14, 2024 | 0 |
| HOLTZMAN STEVEN H | Director | Conversion of Exercise of derivative security | Oct 14, 2024 | 108,946 |
| MANDEL-BREHM JOSH | Chief Executive Officer | Conversion of Exercise of derivative security | Oct 14, 2024 | 272,357 |
| NASHAT AMIR H. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 14, 2024 | 0 |